Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...

In a groundbreaking study, scientists from China have successfully created mice with two biological fathers. Though the ...

We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

CRISPR-Cas9 筛选T细胞分化关键调节因子 接着 ... 转录组测序显示CGRP激活T细胞中第二信使cAMP通路，cAMP的作用与CGRP高度一致，同样可以促进Th1细胞的分化。结合CUT&Tag测序，luciferase，western等实验，研究者进一步探究了CGRP通过RAMP3调控T细胞分化的作用机制：CGRP ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

CRISPR-Cas9 筛选T细胞分化关键调节因子 ... 同样可以促进Th1细胞的分化。结合CUT&Tag测序，luciferase，western等实验，研究者进一步探究了CGRP通过RAMP3 ...

In this article, we will take a look at the Top 11 CRISPR Stocks to Invest in ... and leveraging cutting-edge technologies like pharmacogenomics, digital therapeutics, and artificial intelligence.

SG Americas Securities LLC decreased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 17.9% during the 4th quarter, according to the company in its most recent disclosure with the ...